These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 1833956)

  • 21. Carotid endarterectomy improves cerebrovascular reserve capacity preferentially in patients with preoperative impairment as indicated by asymmetric BOLD response to hypercapnia.
    Goode SD; Altaf N; Auer DP; MacSweeney ST
    Eur J Vasc Endovasc Surg; 2009 Nov; 38(5):546-51. PubMed ID: 19744868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical study of picotamide in patients with vascular diseases].
    Speziale F; Taurino M; Colella E; Rizzo L; Fiorani P
    Recenti Prog Med; 1989 May; 80(5):271-5. PubMed ID: 2762664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hospital management of the acute cerebrovascular patient. Results of a study carried out in the region of Abruzzo].
    Di Mascio R; Marchioli R; Vitullo F; Tognoni G
    Recenti Prog Med; 1996 Nov; 87(11):523-9. PubMed ID: 9122533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of the effectiveness of treatment with diverse doses of cinnarizine of patients with circulatory encephalopathy].
    Shtok VN; Fedorova NV; Pavlov IuV; Traĭtel' BIa
    Klin Med (Mosk); 1989 Sep; 67(9):55-8. PubMed ID: 2586043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Eutergin in the treatment of chronic cerebrovascular disturbance patterns (author's transl)].
    Prosenz P
    Aktuelle Gerontol; 1980 Jun; 10(6):245-51. PubMed ID: 6109460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Open trial of mesoglycan in the treatment of cerebrovascular ischemic disease.
    Mansi D; Sinisi L; De Michele G; Di Geronimo G; Palma V; Brescia Morra V; Coppola N; Buscaino GA
    Acta Neurol (Napoli); 1988 Apr; 10(2):108-12. PubMed ID: 2969172
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of acute and chronic venous pathology of the extremities. Effect of mesoglycan in a case study of 50 patients].
    Florio A; Rosati V; Cioffi G
    Minerva Med; 1986 Oct; 77(41):1933-5. PubMed ID: 2946989
    [No Abstract]   [Full Text] [Related]  

  • 28. [Evaluation of the effects of citicoline in chronic cerebrovascular diseases].
    Sinforiani E; Trucco M; Pacchetti C; Gualtieri S
    Minerva Med; 1986 Jan; 77(1-2):51-7. PubMed ID: 3511406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical and blood rheologic effects of ticlid in patients with cerebrovascular diseases].
    Suslina ZA; Ionova VG; Nikitenko NIu; Maksimova MIu
    Ter Arkh; 1993; 65(9):53-6. PubMed ID: 8303598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Migraine aura lasting 1-24 h in children: a sequence of EEG slow-wave abnormalities vs. vascular events.
    Parain D; Hitzel A; Guegan-Massardier E; Lebas A; Blondeau C; Fédina I; Feray D; Véra P; Mihout B
    Cephalalgia; 2007 Sep; 27(9):1043-9. PubMed ID: 17666084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV
    Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapeutic action of oral mesoglycan in the pharmacologic treatment of the varicose syndrome and its complications].
    Petruzzellis V; Velon A
    Minerva Med; 1985 Mar; 76(12):543-8. PubMed ID: 3157887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Heparan sulfate in the therapy of postphlebitic syndrome. Evaluation of the efficacy and tolerability as compared to mesoglycan].
    Giorgetti PL; Marenghi MC; Bianciardi P
    Minerva Cardioangiol; 1997 Jun; 45(6):279-84. PubMed ID: 9432569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mesoglycan and fibrinolysis: therapeutic activity of oral mesoglycan in venous thrombosis. A short-term clinical, biological and instrumental study].
    Vittoria A; Cappelli R; Messa GL; Auteri A
    Minerva Med; 1986 Oct; 77(40):1867-72. PubMed ID: 2946002
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effects on the coagulation-fibrinolysis system of a single oral dose of mesoglycan at the beginning and at the end of a prolonged treatment in man].
    Blardi P; Messa G; Puccetti L; La Placa G; Ghezzi A
    Recenti Prog Med; 1995; 86(7-8):282-9. PubMed ID: 7569284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of short-term administration of cytidine, uridine and levoglutamine, alone or in combination, on the cerebral electrical activity of patients with chronic cerebrovascular disease.
    Manna V; Martucci N
    Int J Clin Pharmacol Res; 1988; 8(3):199-210. PubMed ID: 3403106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nicardipine in the treatment of outpatients with cerebrovascular disorders.
    Lozano R; Balaguer A
    Clin Ther; 1991; 13(4):496-9. PubMed ID: 1934002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mesoglycan in the treatment of chronic obstructive arteriopathies of the legs].
    Scolari EA
    Clin Ter; 1988 Jul; 126(1):43-7. PubMed ID: 2973958
    [No Abstract]   [Full Text] [Related]  

  • 39. Invos Cerebral Oximeter compared with the transcranial Doppler for monitoring adequacy of cerebral perfusion in patients undergoing carotid endarterectomy.
    Fassiadis N; Zayed H; Rashid H; Green DW
    Int Angiol; 2006 Dec; 25(4):401-6. PubMed ID: 17164748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effectiveness of using cavinton in patients of different ages with chronic forms of cerebrovascular diseases (clinico-rheographic research)].
    Burtsev EM; Shprakh VV; Savkov VS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(1):39-44. PubMed ID: 3364094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.